171 related articles for article (PubMed ID: 25768256)
1. Cadherin 17 is a sensitive and specific marker for metanephric adenoma.
Yakirevich E; Magi-Galluzzi C; Grada Z; Lu S; Resnick MB; Mangray S
Am J Surg Pathol; 2015 Apr; 39(4):479-86. PubMed ID: 25768256
[TBL] [Abstract][Full Text] [Related]
2. [Expression of cadherin17 in metanephric adenoma and its value in differential diagnosis].
Wang X; Wu N; Yang WR; Shi SS; Ma HH; Wei X; Zhou XJ; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2016 Jul; 45(7):457-61. PubMed ID: 27430690
[TBL] [Abstract][Full Text] [Related]
3. Alpha-methylacyl-CoA racemase as a marker in the differential diagnosis of metanephric adenoma.
Olgac S; Hutchinson B; Tickoo SK; Reuter VE
Mod Pathol; 2006 Feb; 19(2):218-24. PubMed ID: 16424894
[TBL] [Abstract][Full Text] [Related]
4. [Molecular features of metanephric adenoma and their values in differential diagnosis].
Wang X; Shi SS; Yang WR; Ye SB; Li R; Ma HH; Zhang RS; Lu ZF; Zhou XJ; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2017 Jan; 46(1):38-42. PubMed ID: 28072975
[No Abstract] [Full Text] [Related]
5. Metanephric adenoma: the utility of immunohistochemical and cytogenetic analyses in differential diagnosis, including solid variant papillary renal cell carcinoma and epithelial-predominant nephroblastoma.
Kinney SN; Eble JN; Hes O; Williamson SR; Grignon DJ; Wang M; Zhang S; Baldrige LA; Martignoni G; Brunelli M; Wang L; Comperat E; Fan R; Montironi R; MacLennan GT; Cheng L
Mod Pathol; 2015 Sep; 28(9):1236-48. PubMed ID: 26248896
[TBL] [Abstract][Full Text] [Related]
6. Metanephric adenoma and solid variant of papillary renal cell carcinoma: common and distinctive features.
Mantoan Padilha M; Billis A; Allende D; Zhou M; Magi-Galluzzi C
Histopathology; 2013 May; 62(6):941-53. PubMed ID: 23551615
[TBL] [Abstract][Full Text] [Related]
7. Embryonal Origin of Metanephric Adenoma and its Differential Diagnosis.
Sarlos DP; Banyai D; Peterfi L; Szanto A; Kovacs G
Anticancer Res; 2018 Dec; 38(12):6663-6667. PubMed ID: 30504374
[TBL] [Abstract][Full Text] [Related]
8. Metanephric adenoma, nephrogenic rests, and Wilms' tumor: a histologic and immunophenotypic comparison.
Muir TE; Cheville JC; Lager DJ
Am J Surg Pathol; 2001 Oct; 25(10):1290-6. PubMed ID: 11688464
[TBL] [Abstract][Full Text] [Related]
9. Fine needle aspiration biopsy of metanephric adenoma: a case report.
Patel NP; Geisinger KR; Zagoria RJ; Bergman S
Acta Cytol; 2009; 53(3):327-31. PubMed ID: 19534278
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical phenotype and molecular pathological characteristics of metanephric adenoma.
Sun Z; Kan S; Zhang L; Zhang Y; Jing H; Huang G; Yu Q; Wu J
Int J Clin Exp Pathol; 2015; 8(6):6031-6. PubMed ID: 26261480
[TBL] [Abstract][Full Text] [Related]
11. The spectrum of metanephric adenofibroma and related lesions: clinicopathologic study of 25 cases from the National Wilms Tumor Study Group Pathology Center.
Arroyo MR; Green DM; Perlman EJ; Beckwith JB; Argani P
Am J Surg Pathol; 2001 Apr; 25(4):433-44. PubMed ID: 11257617
[TBL] [Abstract][Full Text] [Related]
12. Atypical metanephric adenoma: Shares similar histopathological features and molecular changes of metanephric adenoma and epithelial-predominant Wilms' tumor.
Yin X; Zhang X; Pan X; Tan J; Zheng L; Zhou Q; Chen N
Front Oncol; 2022; 12():1020456. PubMed ID: 36313688
[TBL] [Abstract][Full Text] [Related]
13. Tissue-specific cadherin CDH17 is a useful marker of gastrointestinal adenocarcinomas with higher sensitivity than CDX2.
Panarelli NC; Yantiss RK; Yeh MM; Liu Y; Chen YT
Am J Clin Pathol; 2012 Aug; 138(2):211-22. PubMed ID: 22904132
[TBL] [Abstract][Full Text] [Related]
14. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
[TBL] [Abstract][Full Text] [Related]
15. Metanephric Adenoma-Epithelial Wilms Tumor Overlap Lesions: An Analysis of BRAF Status.
Wobker SE; Matoso A; Pratilas CA; Mangray S; Zheng G; Lin MT; Debeljak M; Epstein JI; Argani P
Am J Surg Pathol; 2019 Sep; 43(9):1157-1169. PubMed ID: 31192863
[TBL] [Abstract][Full Text] [Related]
16. CDH17 Is a More Sensitive Marker for Gastric Adenocarcinoma Than CK20 and CDX2.
Altree-Tacha D; Tyrrell J; Haas T
Arch Pathol Lab Med; 2017 Jan; 141(1):144-150. PubMed ID: 28029907
[TBL] [Abstract][Full Text] [Related]
17. The utility of PAX-2 and renal cell carcinoma marker immunohistochemistry in distinguishing papillary renal cell carcinoma from nonrenal cell neoplasms with papillary features.
Sharma SG; Gokden M; McKenney JK; Phan DC; Cox RM; Kelly T; Gokden N
Appl Immunohistochem Mol Morphol; 2010 Dec; 18(6):494-8. PubMed ID: 21102195
[TBL] [Abstract][Full Text] [Related]
18. Clear cell sarcoma, cellular mesoblastic nephroma and metanephric adenoma: cytological features and differential diagnosis with Wilms tumour.
Portugal R; Barroca H
Cytopathology; 2008 Apr; 19(2):80-5. PubMed ID: 17681013
[TBL] [Abstract][Full Text] [Related]
19. S100 protein expression distinguishes metanephric adenomas from other renal neoplasms.
Azabdaftari G; Alroy J; Banner BF; Ucci A; Bhan I; Cheville JC
Pathol Res Pract; 2008; 204(10):719-23. PubMed ID: 18621486
[TBL] [Abstract][Full Text] [Related]
20. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
